Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Gong, Yitao"" wg kryterium: Autor


Tytuł :
Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic Cancer
Autorzy :
Fan, ZhiyaoAff1, Aff2, Aff3, Aff4
Luo, GuopeiAff1, Aff2, Aff3, Aff4
Gong, YitaoAff1, Aff2, Aff3, Aff4
Xu, HeAff1, Aff2, Aff3, Aff4
Qian, YunzhenAff1, Aff2, Aff3, Aff4
Deng, ShengmingAff1, Aff2, Aff3, Aff4
Huang, QiuyiAff1, Aff2, Aff3, Aff4
Yang, ChaoAff1, Aff2, Aff3, Aff4
Cheng, HeAff1, Aff2, Aff3, Aff4
Jin, KaizhouAff1, Aff2, Aff3, Aff4
Liu, ChenAff1, Aff2, Aff3, Aff4
Yu, XianjunAff1, Aff2, Aff3, Aff4
Pokaż więcej
Źródło :
Annals of Surgical Oncology. 27(10):4017-4025
Czasopismo naukowe
Tytuł :
High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumour
Autorzy :
Gong, YitaoAff1, Aff2, Aff3, Aff4
Fan, ZhiyaoAff1, Aff2, Aff3, Aff4
Zhang, PinAff1, Aff2, Aff3, Aff4
Qian, YunzhenAff1, Aff2, Aff3, Aff4
Huang, QiuyiAff1, Aff2, Aff3, Aff4
Deng, ShengmingAff1, Aff2, Aff3, Aff4
Luo, GuopeiAff1, Aff2, Aff3, Aff4
Cheng, HeAff1, Aff2, Aff3, Aff4
Jin, KaizhouAff1, Aff2, Aff3, Aff4
Ni, QuanxingAff1, Aff2, Aff3, Aff4
Yu, XianjunAff1, Aff2, Aff3, Aff4
Liu, ChenAff1, Aff2, Aff3, Aff4
Pokaż więcej
Źródło :
Endocrine: International Journal of Basic and Clinical Endocrinology. :1-8
Czasopismo naukowe
Tytuł :
Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
Autorzy :
Qian, YunzhenAff1, Aff2, Aff3, Aff4
Gong, YitaoAff1, Aff2, Aff3
Fan, ZhiyaoAff1, Aff2, Aff3
Luo, GuopeiAff1, Aff2, Aff3, Aff4
Huang, QiuyiAff1, Aff2, Aff3, Aff4
Deng, ShengmingAff1, Aff2, Aff3, Aff4
Cheng, HeAff1, Aff2, Aff3, Aff4
Jin, KaizhouAff1, Aff2, Aff3, Aff4
Ni, QuanxingAff1, Aff2, Aff3, Aff4
Yu, XianjunAff1, Aff2, Aff3, Aff4
Liu, ChenAff1, Aff2, Aff3, Aff4
Pokaż więcej
Źródło :
Journal of Hematology & Oncology. 13(1)
Czasopismo naukowe
Tytuł :
ASO Author Reflections: C-Reactive Protein/Lymphocyte Ratio as a Promising Marker for Predicting Survival in Pancreatic Cancer
Autorzy :
Fan, ZhiyaoAff1, Aff2, Aff3, Aff4
Luo, GuopeiAff1, Aff2, Aff3, Aff4
Gong, YitaoAff1, Aff2, Aff3, Aff4
Liu, ChenAff1, Aff2, Aff3, Aff4
Yu, XianjunAff1, Aff2, Aff3, Aff4
Pokaż więcej
Źródło :
Annals of Surgical Oncology. 27(10):4026-4027
Czasopismo naukowe
Tytuł :
Prior history of acute pancreatitis predicts poor survival in patients with resectable pancreatic ductal adenocarcinoma
Autorzy :
Gong, Yitao
Pokaż więcej
Źródło :
In Pancreatology June 2020 20(4):716-721
Czasopismo naukowe
Tytuł :
AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN
Autorzy :
Fan, ZhiyaoAff1, Aff2, Aff3, Aff4
Cheng, HeAff1, Aff2, Aff3, Aff4
Jin, KaizhouAff1, Aff2, Aff3, Aff4
Gong, YitaoAff1, Aff2, Aff3, Aff4
Huang, QiuyiAff1, Aff2, Aff3, Aff4
Xu, JinAff1, Aff2, Aff3, Aff4
Ni, QuanxingAff1, Aff2, Aff3, Aff4
Yu, XianjunAff1, Aff2, Aff3, Aff4
Liu, ChenAff1, Aff2, Aff3, Aff4
Luo, GuopeiAff1, Aff2, Aff3, Aff4
Pokaż więcej
Źródło :
World Journal of Surgical Oncology. 17(1)
Czasopismo naukowe
Tytuł :
The role of necroptosis in cancer biology and therapy
Autorzy :
Gong, YitaoAff1, Aff2, Aff3, Aff4
Fan, ZhiyaoAff1, Aff2, Aff3, Aff4
Luo, GuopeiAff1, Aff2, Aff3, Aff4
Yang, ChaoAff1, Aff2, Aff3, Aff4
Huang, QiuyiAff1, Aff2, Aff3, Aff4
Fan, KunAff1, Aff2, Aff3, Aff4
Cheng, HeAff1, Aff2, Aff3, Aff4
Jin, KaizhouAff1, Aff2, Aff3, Aff4
Ni, QuanxingAff1, Aff2, Aff3, Aff4
Yu, XianjunAff1, Aff2, Aff3, Aff4
Liu, ChenAff1, Aff2, Aff3, Aff4
Pokaż więcej
Źródło :
Molecular Cancer. 18(1)
Czasopismo naukowe
Tytuł :
Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients.
Autorzy :
Gong, Yitao
Fan, Zhiyao
Luo, Guopei
Huang, Qiuyi
Qian, Yunzhen
Cheng, He
Jin, Kaizhou
Ni, Quanxing
Yu, Xianjun
Liu, Chen
Pokaż więcej
Temat :
PROGRESSION-free survival
LYMPHOCYTE subsets
KILLER cells
LYMPHOCYTE count
B cells
PANCREATIC tumors
Źródło :
Cancer Management & Research; Aug2020, Vol. 12, p6727-6737, 11p
Czasopismo naukowe
Tytuł :
The CRP/Albumin Ratio Predicts Survival And Monitors Chemotherapeutic Effectiveness In Patients With Advanced Pancreatic Cancer.
Autorzy :
Fan, Zhiyao
Fan, Kun
Gong, Yitao
Huang, Qiuyi
Yang, Chao
Cheng, He
Jin, Kaizhou
Ni, Quanxing
Yu, Xianjun
Luo, Guopei
Liu, Chen
Pokaż więcej
Temat :
PANCREATIC cancer
PROPORTIONAL hazards models
ALBUMINS
MULTIVARIATE analysis
PANCREATIC intraepithelial neoplasia
Źródło :
Cancer Management & Research; Sep2019, Vol. 11, p8781-8788, 8p
Czasopismo naukowe
Tytuł :
Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms.
Autorzy :
Deng S; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China.
Fan Z; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China.
Xia H; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China.
Gong Y; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China.
Qian Y; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China.
Huang Q; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China.
Cheng H; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China.
Jin K; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China.
Xiao Z; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China.
Luo G; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China.
Yu X; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China.
Liu C; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China.
Pokaż więcej
Źródło :
Cancer management and research [Cancer Manag Res] 2021 Jan 08; Vol. 13, pp. 107-115. Date of Electronic Publication: 2021 Jan 08 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies